<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Skovgaard Grady | Activity</title>
	<link>https://toxicdolls.com/members/changeloss3/activity/</link>
	<atom:link href="https://toxicdolls.com/members/changeloss3/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Skovgaard Grady.</description>
	<lastBuildDate>Thu, 14 May 2026 01:32:09 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">9a2b0672b390a239b8f312e0a9a22c7b</guid>
				<title>Skovgaard Grady posted an update: Following influenza infection, rs2248374-G ERAP2 expressing [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/11870/</link>
				<pubDate>Thu, 26 Jun 2025 12:11:01 +0000</pubDate>

									<content:encoded><![CDATA[<p>Following influenza infection, rs2248374-G ERAP2 expressing cells may transcribe an alternative spliced isoform ERAP2/Iso3. This variant, unlike ERAP2-wt, is unable to trim peptides to be loaded on MHC class I molecules, but it can still dimerize with both ERAP2-wt and ERAP1-wt, thus contributing to profiling an alternative cellular&hellip;<span class="activity-read-more" id="activity-read-more-11870"><a href="https://toxicdolls.com/activity-2/p/11870/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8c01f95f57889aaaec196ec612e7c1f9</guid>
				<title>Skovgaard Grady posted an update: One foot in the Group 1 relapsed, while three feet in Group 2 [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/11468/</link>
				<pubDate>Wed, 25 Jun 2025 11:47:04 +0000</pubDate>

									<content:encoded><![CDATA[<p>One foot in the Group 1 relapsed, while three feet in Group 2 relapsed, but the difference was also not statistically significant. All of the relapsed feet were successfully treated with repeated Ponseti method.</p>
<p> Treating CTEV using Ponseti method starting after one month was not associated with more casting change of higher rate of&hellip;<span class="activity-read-more" id="activity-read-more-11468"><a href="https://toxicdolls.com/activity-2/p/11468/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">db68e0ba44c61a9f48f02687986f9953</guid>
				<title>Skovgaard Grady posted an update: Single-center trials and retrospective case series have [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/10238/</link>
				<pubDate>Tue, 24 Jun 2025 12:44:20 +0000</pubDate>

									<content:encoded><![CDATA[<p>Single-center trials and retrospective case series have reported promising outcomes using kidneys from donors with hepatitis C virus (HCV) infection. However, multicenter trials are needed to determine if those findings are generalizable.</p>
<p> We conducted a prospective trial at seven centers to transplant 30 kidneys from deceased donors with&hellip;<span class="activity-read-more" id="activity-read-more-10238"><a href="https://toxicdolls.com/activity-2/p/10238/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1481e0ac4726666cbafda89a8360941a</guid>
				<title>Skovgaard Grady became a registered member</title>
				<link>https://toxicdolls.com/activity-2/p/8280/</link>
				<pubDate>Mon, 23 Jun 2025 10:58:05 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>